Denghui Chen

Title: The Innovations of Denghui Chen

Introduction

Denghui Chen is a notable inventor based in Wuhan, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating respiratory disorders. His work has led to the filing of a patent that showcases his innovative approach to drug development.

Latest Patents

Denghui Chen holds a patent for "Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors." This patent relates to novel imidazopyridinyl- or imidazopyrimidinyl-substituted, bridged 1,4-diazepane derivatives. The application outlines processes for their preparation and their use in treating and preventing diseases, especially respiratory disorders such as obstructive sleep apneas and snoring. The formula presented in the patent includes a bridged 1,4-diazepane cycle, which is crucial for its therapeutic applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Denghui Chen has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Denghui Chen has worked alongside talented professionals such as Martina Delbeck and Michael Hahn. These collaborations have enriched his research and have been instrumental in advancing his innovative projects.

Conclusion

Denghui Chen's contributions to medicinal chemistry and his innovative patent demonstrate his commitment to improving healthcare through scientific advancements. His work continues to inspire future research in the treatment of respiratory disorders.